Silvercrest Asset Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $284K | Hold |
3,144
| – | – | ﹤0.01% | 773 |
|
|
2025
Q4 | $283K | Hold |
3,144
| – | – | ﹤0.01% | 801 |
|
|
2025
Q3 | $310K | Sell |
3,144
-10
| -0.3% | -$991 | ﹤0.01% | 753 |
|
|
2025
Q2 | $288K | Sell |
3,154
-985
| -24% | -$95.2K | ﹤0.01% | 769 |
|
|
2025
Q1 | $468K | Buy |
4,139
+635
| +18% | +$67.9K | ﹤0.01% | 710 |
|
|
2024
Q4 | $370K | Hold |
3,504
| – | – | ﹤0.01% | 733 |
|
|
2024
Q3 | $378K | Sell |
3,504
-67
| -2% | -$7.31K | ﹤0.01% | 688 |
|
|
2024
Q2 | $388K | Hold |
3,571
| – | – | ﹤0.01% | 766 |
|
|
2024
Q1 | $471K | Sell |
3,571
-306
| -8% | -$38.2K | ﹤0.01% | 717 |
|
|
2023
Q4 | $472K | Buy |
3,877
+12
| +0.3% | +$1.34K | ﹤0.01% | 678 |
|
|
2023
Q3 | $434K | Buy |
3,865
+40
| +1% | +$5.08K | ﹤0.01% | 698 |
|
|
2023
Q2 | $557K | Sell |
3,825
-356
| -9% | -$48.4K | ﹤0.01% | 664 |
|
|
2023
Q1 | $540K | Sell |
4,181
-513
| -11% | -$64.4K | ﹤0.01% | 641 |
|
|
2022
Q4 | $598K | Hold |
4,694
| – | – | ﹤0.01% | 624 |
|
|
2022
Q3 | $491K | Hold |
4,694
| – | – | ﹤0.01% | 641 |
|
|
2022
Q2 | $494K | Sell |
4,694
-5
| -0.1% | -$593 | ﹤0.01% | 643 |
|
|
2022
Q1 | $601K | Sell |
4,699
-1,943
| -29% | -$234K | ﹤0.01% | 662 |
|
|
2021
Q4 | $820K | Sell |
6,642
-206
| -3% | -$27K | 0.01% | 606 |
|
|
2021
Q3 | $973K | Sell |
6,848
-62
| -0.9% | -$9.12K | 0.01% | 580 |
|
|
2021
Q2 | $1.08M | Sell |
6,910
-57
| -0.8% | -$9.23K | 0.01% | 561 |
|
|
2021
Q1 | $1.08M | Buy |
6,967
+10
| +0.1% | +$1.55K | 0.01% | 554 |
|
|
2020
Q4 | $1.04M | Sell |
6,957
-1,106
| -14% | -$156K | 0.01% | 531 |
|
|
2020
Q3 | $1.07M | Sell |
8,063
-4,276
| -35% | -$559K | 0.01% | 514 |
|
|
2020
Q2 | $1.43M | Buy |
12,339
+82
| +0.7% | +$9.45K | 0.01% | 497 |
|
|
2020
Q1 | $1.2M | Buy |
12,257
+844
| +7% | +$111K | 0.01% | 481 |
|
|
2019
Q4 | $1.66M | Sell |
11,413
-19
| -0.2% | -$2.62K | 0.01% | 495 |
|
|
2019
Q3 | $1.52M | Sell |
11,432
-24
| -0.2% | -$3.1K | 0.01% | 500 |
|
|
2019
Q2 | $1.31M | Sell |
11,456
-58
| -0.5% | -$6.79K | 0.01% | 361 |
|
|
2019
Q1 | $1.43M | Buy |
11,514
+994
| +9% | +$113K | 0.01% | 352 |
|
|
2018
Q4 | $1.06M | Sell |
10,520
-313
| -3% | -$35.2K | 0.01% | 342 |
|
|
2018
Q3 | $1.38M | Sell |
10,833
-1,538
| -12% | -$183K | 0.01% | 338 |
|
|
2018
Q2 | $1.34M | Sell |
12,371
-175
| -1% | -$19K | 0.01% | 347 |
|
|
2018
Q1 | $1.33M | Sell |
12,546
-101
| -0.8% | -$11.7K | 0.01% | 348 |
|
|
2017
Q4 | $1.48M | Buy |
12,647
+695
| +6% | +$78.6K | 0.01% | 340 |
|
|
2017
Q3 | $1.36M | Sell |
11,952
-1,509
| -11% | -$174K | 0.01% | 341 |
|
|
2017
Q2 | $1.68M | Sell |
13,461
-1,075
| -7% | -$127K | 0.02% | 321 |
|
|
2017
Q1 | $1.72M | Sell |
14,536
-737
| -5% | -$83.5K | 0.02% | 311 |
|
|
2016
Q4 | $1.53M | Buy |
15,273
+3
| +0% | +$322 | 0.02% | 312 |
|
|
2016
Q3 | $1.93M | Sell |
15,270
-72
| -0.5% | -$8.9K | 0.02% | 296 |
|
|
2016
Q2 | $1.79M | Buy |
15,342
+709
| +5% | +$80.2K | 0.02% | 294 |
|
|
2016
Q1 | $1.51M | Sell |
14,633
-24,246
| -62% | -$2.35M | 0.02% | 302 |
|
|
2015
Q4 | $3.87M | Buy |
38,879
+3
| +0% | +$294 | 0.05% | 231 |
|
|
2015
Q3 | $3.54M | Hold |
38,876
| – | – | 0.05% | 219 |
|
|
2015
Q2 | $4.12M | Buy |
38,876
+611
| +2% | +$67.6K | 0.06% | 238 |
|
|
2015
Q1 | $4.37M | Hold |
38,265
| – | – | 0.06% | 211 |
|
|
2014
Q4 | $4.21M | Sell |
38,265
-3,090
| -7% | -$326K | 0.06% | 213 |
|
|
2014
Q3 | $4.04M | Hold |
41,355
| – | – | 0.06% | 218 |
|
|
2014
Q2 | $4.17M | Sell |
41,355
-1,854
| -4% | -$181K | 0.06% | 219 |
|
|
2014
Q1 | $3.97M | Sell |
43,209
-179
| -0.4% | -$16.5K | 0.06% | 206 |
|
|
2013
Q4 | $3.92M | Hold |
43,388
| – | – | 0.07% | 206 |
|
|
2013
Q3 | $3.46M | Hold |
43,388
| – | – | 0.07% | 206 |
|
|
2013
Q2 | $3.16M | Buy |
+43,388
| New | +$3.24M | 0.07% | 200 |
|
Other funds holding ZBH
VCM
VPM
Silvercrest Asset Management's ZBH Position: Q1 2026 in Review
Silvercrest Asset Management held its Zimmer Biomet (ZBH) position steady in Q1 2026 at 3,144 shares worth $284K. The position accounts for ﹤0.01% of the portfolio, ranked #773.
Silvercrest Asset Management first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.37M in Q1 2015. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Silvercrest Asset Management held 3,144 shares of Zimmer Biomet worth $284K as of Q1 2026.
- Silvercrest Asset Management left its Zimmer Biomet share count unchanged in Q1 2026.
- Zimmer Biomet made up ﹤0.01% of Silvercrest Asset Management's portfolio in Q1 2026, its #773 holding.
- Silvercrest Asset Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
- Silvercrest Asset Management's Zimmer Biomet position peaked at $4.37M in Q1 2015.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Silvercrest Asset Management's 13F filing for Q1 2026, filed 15 May 2026.